Cargando…

215b. Real-World Experience of Letermovir Use at an Academic Transplant Center

BACKGROUND: Letermovir (LMV) is indicated for cytomegalovirus (CMV) prophylaxis in seropositive adults after allogeneic hematopoietic stem cell transplants (alloSCT). LMV is well tolerated compared to its alternatives. Our institution restricts LMV use to high-risk patient groups to maximize the cos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, HaYoung, Bowen, Christina, Bubalo, Joseph, Yu, Diana, Lewis, James S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752881/
http://dx.doi.org/10.1093/ofid/ofac492.293

Ejemplares similares